Segal NH, Cercek A, Ku GY, Wu AJ, et al. Phase II Single Arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair Proficient Metastatic Colorectal Cancer. Clin Cancer Res 2021 Jan 27. pii: 1078-0432.CCR-20-2474.
PMID: 33504552